Question & AnswerQ&A (DDB BOARD REGULATION NO. 3, S. 1995)
Aminorex, brotizolam, etryptamine, flunitrazepam, mesocard, methcathinone, and zipeprol, including their salts, isomers, and salts of isomers, and preparations containing said substances are classified as prohibited drugs.
The classification is based on Section 36(a) of Republic Act 6425 as amended.
The recommendation of the Secretary General of the World Health Organization (WHO) to place aminorex, brotizolam, etryptamine, flunitrazepam, mesocard, methcathinone, and zipeprol under international control influenced the listing.
The substances have the capacity to produce dependence and are likely to be abused, thus constituting a public health and social problem.
Violations can lead to administrative action and criminal prosecution if warranted.
It took effect fifteen (15) days after its publication in a newspaper of general circulation once a week for two consecutive weeks.
The regulation was adopted and signed by Manuel G. Roxas, M.D., M.P.H., Undersecretary of Health and Chief of Staff, Vice-Chairman and Presiding Officer of the Dangerous Drugs Board.
Prohibited drugs are substances banned entirely because of their potential for abuse and harm, while regulated drugs are controlled substances subject to specific government regulations (specific substances under regulated drugs are not listed here but are distinguished under the regulation).
Section I lists the substances classified as prohibited drugs.
The evaluation justifies their classification and regulation under Philippine law to prevent abuse and protect public health and safety.